(1)
Intravenous Immunoglobulin: A Potential Treatment for the Post-Acute Sequelae of SARS-Cov-2 Infection?. Biomol Biomed 2022, 22 (4), 660-664. https://doi.org/10.17305/bjbms.2021.6901.